Table 1 Correlation between the clinicopathologic features and expression of NKILA
Characteristics | NKILA relative expression N (%) | p | |
|---|---|---|---|
Low expression (53) | High expression (53) | ||
Age (y) | |||
< 60 | 27 (48.2) | 29 (51.8) | 0.697 |
≥ 60 | 26 (52.0) | 24 (48.0) | |
Gender | |||
Male | 36 (49.3) | 37 (50.7) | 0.834 |
Female | 17 (51.5) | 16 (48.5) | |
Differentiated degree | |||
Well | 1 (1.9) | 5 (9.4) | 0.212 |
Media | 33 (62.3) | 28 (52.8) | |
Poor | 19 (35.8) | 20 (37.7) | |
Pathological type | |||
Squamous carcinoma | 26 (49.1) | 27 (50.9) | 0.846 |
Adenocarcinoma | 27 (50.9) | 26 (49.1) | |
Clinical stage | |||
I-II | 25 (44.1) | 34 (55.9) | 0.048 * |
III-IV | 29 (57.4) | 18 (42.6) | |
T stage | |||
I-II | 36 (43.4) | 47 (56.6) | 0.010 * |
III-IV | 17 (73.9) | 6 (16.1) | |
Tumor size | |||
< 3 cm | 10 (32.3) | 21 (67.7) | 0.019 * |
≥ 3 cm | 43 (57.3) | 32 (42.7) | |
Lymph node metastasis | |||
Negative | 18 (34.6) | 34 (63.4) | 0.002 * |
Positive | 35 (64.8) | 19 (35.2) | |